Table 3 Large-scale comparison between KEGG spider and GENECODIS

Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma [40]

Table 1: proteins found to be differentially expressed between matched normal and RCC primary lines

Proteomic analysis of anaplastic lymphoma cell lines: identification of potential tumour markers [41]

Table 2: proteins overexpressed in FE-PD cells compared to SU-DHL-1 cells

Differential expression profiling of human pancreatic adenocarcinoma and healthy pancreatic tissue [42]

Table 3: proteins at higher levels in normal pancreas compared to pancreatic cancer

Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma [43]

Table 1: differentially expressed proteins in human ovarian cancer cells

Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma [44]

Table 3: differentially expressed proteins in RCC patients

Protein profile changes in the human breast cancer cell line MCF-7 in response to SEL1L [45]

Table 4: MCF7-SEL1L differentially expressed genes identified by microarray analysis

Protein dysregulation in mouse hippocampus polytransgenic for chromosome 21 structures in the Down syndrome critical region [46]

Table 2: list of proteins dysregulated in hippocampus of polytransgenic micea

Differential expression of proteins in response to ceramide-mediated stress signal in colon cancer cells by 2-D gel electrophoresis and MALDI-TOF-MS [47]

Table 1: list of identified proteins on HCT116 2-DE gels

Subcellular proteome analysis of camptothecin analogue NSC606985-treated acute myeloid leukemic cells [48]

Table 2: functional classifications of the deregulated proteins in NSC606985-induced apoptotic NB4 Cellsa

Proteome analysis of responses to ascochlorin in a human osteosarcoma cell line by 2-D gel electrophoresis and MALDI-TOF MS [49]

Table 2: differentially expressed proteins in ascochlorin-treated U2OS cells

Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells [50]

Table 1: summary of differentially expressed proteins and their functional classifications

Proteomic analysis of the resistance to aplidin in human cancer cells [51]

Table 1: differentially expressed proteins between resistant and wild-type HeLa cells identified in the membrane fraction

Proteomic analysis of the resistance to aplidin in human cancer cells [51]

Table 2: differentially expressed proteins between resistant and wild-type HeLa cells identified in the cytosolic fraction

Identification of specific protein markers in microdissected hepatocellular carcinoma

Table 2: identified proteins from HCC and nontumorous liver tissue by in-gel digestion and SELDI-MS

Comparison of membrane-associated proteins in human cholangiocarcinoma and hepatocellular carcinoma cell lines [52]

Table 1: list of proteins from the membrane fraction of HuCCA-1 and HCC-S102 cell lines which show up-regulated expression

Contribution of laser microdissection-based technology to proteomic analysis in hepatocellular carcinoma developing on cirrhosis [53]

Table 1: proteins differentially expressed in tumorous LM-hepatocytes and total homogenates samples identified PMF

Proteome alterations induced in human white blood cells by consumption of Brussels sprouts: results of a pilot intervention study [54]

Table 1: protein alterations induced by a controlled dietary intervention with Brussels sprouts in human primary white blood cells